Key result
COVID-19-associated pulmonary embolism shows no increase in CTEPH or impaired thrombus resolution versus non-COVID-19 PE.
Why the study?
Does COVID-19-associated pulmonary embolism increase the long-term risk of CTEPH or affect thrombus resolution compared to non-COVID-19-associated pulmonary embolism?
Cross-Sectional
Yes
Does COVID-19-associated pulmonary embolism increase the long-term risk of CTEPH or affect thrombus resolution compared to non-COVID-19-associated pulmonary embolism?
COVID-19-associated pulmonary embolism does not appear to carry a higher long-term risk of CTEPH or worse thrombus resolution compared to non-COVID-19 pulmonary embolism.
Answers are grounded in this paper and cite their sources.
Reassures against heightened CTEPH surveillance after COVID-19 PE; leaves open confirmation in larger prospective cohorts.
The incidence of chronic thromboembolic pulmonary hypertension (CTEPH) in coronavirus disease 2019 (COVID-19) survivors who were diagnosed with acute pulmonary embolism (PE) is currently unknown. Considering the high PE incidence reported in COVID-19 and its potentially unique pathophysiology, it may be hypothesised that thrombus resolution occurs to a lesser extent after COVID-19-associated PE, and that the prevalence of CTEPH is higher compared to non-COVID-19-associated PE populations. CTEPH could therefore be a treatable cause of long COVID, which captures a broad range of post-acute COVID-19 sequelae, in those with PE during acute COVID-19 [1]. In this multicentre cross-sectional study, we aimed to establish the prevalence of CTEPH and recurrent venous thromboembolism (VTE), and evaluate thrombus resolution in COVID-19-associated PE survivors. The results of this study suggest that CTEPH is not a more common long-term complication after COVID-19-associated PE than after PE in non-COVID-19 patients, and thrombus resolution did not seem to be different from non-COVID-19-associated PE https://bit.ly/3IjvWL3
No takes yet. Share an insight, caveat, or question.
Jong et al. (2023) conducted a cross-sectional in COVID-19-associated pulmonary embolism. COVID-19-associated pulmonary embolism vs. Non-COVID-19-associated pulmonary embolism was evaluated on Prevalence of chronic thromboembolic pulmonary hypertension (CTEPH), recurrent venous thromboembolism (VTE), and thrombus resolution. COVID-19-associated pulmonary embolism did not show a higher prevalence of CTEPH or impaired thrombus resolution compared with non-COVID-19-associated pulmonary embolism.
Synapse has enriched 10 related papers. Consider them for comparative context: